AKT1 and lip and oral cavity carcinoma: Additionally, treatment of cisplatin-resistant human oral cancer (CAR) cells with PS (50–75 μM) resulted in decreased cell viability through stimulation of apoptotic caspase activation and reduced Akt activation (Derici et al., 2021).